No insider purchase over the last 90 days. The latest was filed 09 Dec 2025.
Every trade that managers of Cross Country Healthcare Inc disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector. From 18 October 2025 to 18 October 2026, the disclosure feed for Cross Country Healthcare Inc logged 59 filings by 16 insiders.
Both sides are active: 1 purchase worth €1,392 and 1 sale worth €52k, from 1 insider and 1 insider respectively. Sales outweigh purchases by €50k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a sale of €52k by McDonald Colin Patrick, published on 12 March 2026. Those buying include 1 senior executive.
The last insider purchase was made public on 9 December 2025, 313 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction.
Across the 5,810 companies tracked on its exchange, the median is 19 filings; at 59 filings, this issuer sits above that mark. The full history, which starts in 2016, counts 5 purchases against 31 sales. The 10-K for the year ended 31 December 2025 shows 1.05 bn USD of revenue and -94.9 m USD of net income.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Cross Country Healthcare Inc Hold (neutral), based on 4 analysts. Average price target: US$12.44.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 209 declarations
Cross Country Healthcare, Inc. (ticker: CCRN) is a U.S.-based healthcare workforce solutions company listed on the NASDAQ in the United States. Headquartered in Boca Raton, Florida, the company has been active for nearly 40 years in healthcare staffing and workforce services. Its positioning goes beyond traditional recruitment: Cross Country offers an AI-powered digital platform, advisory services, and workforce optimization solutions designed to help health systems better manage staffing, control labor costs, and preserve continuity of care. ([ir.crosscountryhealthcare.com](https://ir.crosscountryhealthcare.com/))
The company operates through two reportable segments. Nurse and Allied Staffing covers temporary placements of nurses, allied health professionals, and related healthcare labor; Physician Staffing provides physicians, CRNAs, nurse practitioners, and physician assistants on temporary assignments. In 2024, these two segments represented roughly 85% and 15% of revenue, respectively. Cross Country serves a broad and diversified customer base across the United States, including acute-care and non-acute-care facilities, medical groups, managed care organizations, government facilities, and other healthcare providers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1141103/000114036125039464/ny20055089x3_ars.pdf))
From a competitive perspective, Cross Country operates in a market supported by persistent healthcare labor shortages and strong demand from providers for flexible staffing models. The company emphasizes a wider service mix than a pure staffing agency, including MSP, VMS, in-home care services, education health services, RPO, project management, and consulting capabilities. That broader offering supports a more integrated value proposition for health systems seeking to optimize their entire labor ecosystem rather than simply fill open shifts. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1141103/000114036125039464/ny20055089x3_ars.pdf))
Recent corporate developments have been dominated by M&A. On December 3, 2024, Cross Country entered into a merger agreement with Aya Healthcare. In February 2025, the companies received additional information requests from the FTC, and the company later indicated that closing was expected in the second half of 2025. However, as of May 6, 2026, Cross Country announced an all-cash acquisition by Knox Lane valued at $437 million. In parallel, the company continued to expand its technology-led offerings, including the May 2026 launch of an enhanced Optimé solution to power Intellify with more advanced forecasting and staffing optimization capabilities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1141103/000114036125039464/ny20055089x3_ars.pdf))
For investors, CCRN is best viewed as a NASDAQ-listed U.S. healthcare staffing and workforce platform with exposure to cyclical labor demand, but also to structural healthcare staffing needs and technology-enabled workflow optimization.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 1.05 bn USD | -94.9 m USD | -2.93 USD | 10-K |
| Dec 2024 | 1.34 bn USD | -14.6 m USD | -0.44 USD | 10-K |
| Dec 2023 | 2.02 bn USD | 72.6 m USD | 2.05 USD | 10-K |
| Dec 2022 | 2.80 bn USD | 188.5 m USD | 4.95 USD | 10-K |
| Dec 2021 | 1.68 bn USD | 132.0 m USD | 3.53 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.